Medical Research
(H12)
990 on File
MICHAEL TOSHIO CURE FOR CANCER FOUNDATION
Financial strength (30%)
82/100
Reliability (20%)
45/100
Effectiveness (25%)
41/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$1.1M
Total Revenue
$739K
Total Expenses
$14.1M
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
66.9%
Fundraising Efficiency
N/A
Operating Reserve
229.10x
Liability-to-Asset
0.2%
Revenue Diversification
78.2%
Executive Compensation
$276K
Compared with Peers
FY 2024
Compared with 726 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
66.9% | 84.5% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
229.1 mo | 13.4 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.2% | 0.4% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
78.2% | 93.3% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
44.2% | 9.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-32.1% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
34.3% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $1.1M | $739K | $14.1M | 66.9% | — |
| 2023 | $780K | $1.1M | $13.1M | 69.6% | — |
| 2022 | $5.6M | $683K | $11.9M | 64.6% | — |
| 2021 | $7.5M | $37K | $7.5M | 0.0% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.